✦ LIBER ✦

Radioimmunotherapy with131I-Rituximab in a Patient with Diffuse Large B-Cell Lymphoma Relapsed After Treatment with90Y-Ibritumomab Tiuxetan

✍ Scribed by Kang, Geon Wook; Kang, Hye Jin; Shin, Dong-Yeop; Gu, Ha Ra; Choi, Hong Seok; Lim, Sang Moo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of radioimmunotherapy with

✍ Takashi Watanabe; Shoji Terui; Kuniaki Itoh; Takashi Terauchi; Tadahiko Igarashi 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

Japanese phase II study of 90Y-ibritumom

✍ Kensei Tobinai; Takashi Watanabe; Michinori Ogura; Yasuo Morishima; Tomomitsu Ho 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Biodistribution, radiation dosimetry and

✍ Saiyada N. F. Rizvi; Otto J. Visser; Maria J. W. D. Vosjan; Arthur van Lingen; O 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 284 KB

Factors associated with effects of90Y-ib

✍ Uike, Naokuni; Choi, Ilseung; Tsuda, Mariko; Haji, Shojirou; Toyoda, Kousuke; Su 📂 Article 📅 2014 🏛 Carden Jennings Publishing 🌐 English ⚖ 600 KB

Treatment with yttrium 90 ibritumomab ti

✍ Emmanouilides, Christos; Witzig, Thomas E.; Gordon, Leo I.; Vo, Katie; Wiseman, 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 352 KB

A Novel Platform for Radioimmunotherapy:

✍ Lindén, Ola; Kurkus, Jan; Garkavij, Michael; Cavallin-Ståhl, Eva; Ljungberg, Mic 📂 Article 📅 2005 🏛 Mary Ann Liebert 🌐 English ⚖ 147 KB